Wolverine Stack
Two recovery peptides used together, with the gap in the evidence stated rather than glossed.
- Explored for soft-tissue recovery support
- Two peptides thought to act by different routes
- Used alongside a loading and recovery plan, not in place of one
Explored, not established. No published trial has compared this combination against either component on its own, so any claim that the pair outperforms one is unsupported.
Pricing confirmed after eligibility · prescription treatment
What is in the Wolverine Stack
The Wolverine Stack pairs BPC-157 with TB-500, a synthetic fragment related to thymosin beta-4. Both are studied for a role in tissue repair, and the reasoning behind combining them is that they are thought to act by different routes. Both are prepared by a licensed compounding pharmacy under a prescription written for you; neither is FDA-approved and neither is equivalent to any branded medication.
How it works here
Every plan follows one path. Each step feeds the next. See the Peptide Therapy approach.
- 01
Measure
We baseline your labs, history, and goals.
- 02
Plan
A clinician decides whether this fits — and what else might serve you.
- 03
Act
If appropriate, you start with clear guidance and high-touch support.
- 04
Track
We monitor how you respond on a defined cadence.
- 05
Adjust
Protocols are refined over time. Guided care, not a kit in the mail.
Delivery
A compounded preparation, dispensed by a licensed pharmacy on an individual prescription. How it is taken is set by the prescribing clinician after a review.
Is it right for you?
Adults over 45 with a specific recovery problem who have already addressed the basics and want the combination explained honestly, including what is not known about it. See peptide therapy.
Often considered alongside
BPC-157
CompoundedA recovery peptide with far more discussion than proof — offered with the evidence stated plainly.
View treatmentRepair & Recovery Stack
CompoundedThree recovery peptides in one protocol, with each component's evidence described separately.
View treatmentSermorelin ODT
CompoundedThe needle-free route to sermorelin — offered honestly, including what we can't tell you about it.
View treatmentProducts marked Compounded are prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved and are not equivalent to or interchangeable with any branded product.
An honest word on the evidence
The honest position on this stack is narrower than the marketing around it. Each component has its own preclinical literature and very little human data, and the combination has neither: no published trial compares it with BPC-157 alone or TB-500 alone. So the case for pairing them is mechanistic reasoning, not evidence of an additive effect, and it should be described that way. These peptides sit in an unsettled regulatory position. In April 2026 the FDA removed twelve peptide substances from Category 2 of its interim 503A bulk substances list, this one among them — a step that followed the nominators withdrawing their nominations rather than any safety finding, and one that does not by itself authorize compounding. In July 2026 the Pharmacy Compounding Advisory Committee voted on whether seven of them should be added to the 503A Bulks List. That vote is a recommendation, not a decision: formal addition requires notice-and-comment rulemaking, which has not completed. Nothing here is FDA-approved for any use.
Frequently asked questions
Nobody can say. No published trial has compared them. What adding TB-500 is meant to do sets out the reasoning and its limits.
A synthetic fragment related to thymosin beta-4, studied for a role in tissue repair and blood-vessel formation, largely in preclinical models.
No. Neither is approved for any use, and both are compounded preparations.
It is a nickname the peptide community gave it, not a clinical term, and it sets an expectation the evidence does not support.
See if Wolverine Stack fits your plan
The right plan begins with knowing where you are. Start with a short eligibility check and a baseline — and we'll tell you, honestly, what fits.
We measure first. Then we act.
ACT 2 Health provides clinician-led care. Treatments described are available only to eligible patients following clinical evaluation and within applicable regulations. This page is educational and is not medical advice. Individual results vary.